CANCER BUZZ TV

In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, clinical pharmacy specialist in oncology at University of Pittsburgh – Passavant Hospital, and Victoria Nachar, PharmD, BCOP, clinical pharmacist specialist in ambulatory hematology and adjunct clinical instructor at the University of Michigan, about strategies to address common adverse events experienced by patients with mantle cell lymphoma.  

In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor at Emory University School of Medicine in Atlanta, Georgia, about fostering trust, rapport, and collaboration in the patient-provider relationship.

In this episode, CANCER BUZZ speaks with David Sallman, MD, associate member in the Department of Malignant Hematology at Moffitt Cancer Center, and Karley Trautman, DNP, ANP-BC, AGACNP-BC, senior instructor of Medical Oncology at Highlands Ranch Cancer Center, to discuss best practices in the management of anemia in low-risk MDS patients.

Gain insights on reshaping multidisciplinary cancer care team workflows to enable laboratory professionals to improve biomarker testing efficiency.

In this episode, CANCER BUZZ speaks with Steven Gilmore, PharmD, BCOP, Senior Manager of Clinical Content in Pharmacy and Clinical Programs with McKesson Specialty Health, and Christopher Benton, MD, hematologist and medical oncologist at Rocky Mountain Cancer Centers, to review key considerations and emerging trends for the treatment of anemia in the low-risk MDS population.  

In this episode, CANCER BUZZ TV speaks with Tom Lycan, DO, MHS, assistant professor of Hematology & Oncology at the Wake Forest School of Medicine, about a practical tool that can provide a care plan roadmap for providers and patients to mitigate precision medicine disparities.

In this episode, CANCER BUZZ speaks with Amy DeZern, MD, MHS, director, Bone Marrow Failure and MDS Program, Johns Hopkins University School of Medicine in Baltimore, Maryland; Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, clinical oncology pharmacy manager, Atrium Health Levine Cancer in Charlotte, North Carolina; and David Sallman, MD, assistant member, Department of Malignant Hematology, Moffitt Cancer Center in Tampa, Florida. Their discussion elucidates an array of patient-centered approaches, touches on social determinants of health, and highlights collaborative measures to support care coordination in the management of anemia in patients with high-risk myelodysplastic syndrome and acute myeloid leukemia.

In this episode, CANCER BUZZ speaks with Raymond Liu, MD, director of research of Hematology-Oncology in Kaiser Permanente Northern California, director of cancer survivorship in Kaiser Permanente San Francisco, and assistant clinical professor at UCSF, who shares how successful implementation of the 4R Oncology® model empowers patients and clinicians and coheres care teams.

Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate professor in Population Health Sciences at Duke Cancer Institute, about the importance of keeping patients with acute myeloid leukemia in first remission as long as possible through maintenance therapy. 

Coordination of care for patients diagnosed with acute myeloid leukemia, particularly those who are ineligible for transplant, can impact access to specialist care, clinical trials, and cancer programs with advanced capabilities to treat patients with acute myeloid leukemia.

In this episode, CANCER BUZZ speaks with Farrukh T. Awan, MD, MS, professor of Internal Medicine and director of Lymphoid Malignancies at the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, about their approach to addressing regional barriers to improve care for patients with chronic lymphocytic leukemia.

Personalizing care goals to account for a patient’s values, preferences, or circumstances can make a significant difference in shared decision-making and treatment planning. In this episode, CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology at the University of Rochester Medical Center’s Wilmot Cancer Institute about strategies to optimize critical conversations with patients with acute myeloid leukemia.

Significant declines in the screening, diagnosis, and treatment of patients with small cell lung cancer have increased challenges that impact patient care. Many patients with small cell lung cancer have a high symptom burden, poor prognosis, adherence challenges due to treatment-related adverse events, stigmatization, and emotional distress. The team at Atrium Health’s Levine Cancer Institute is testing supportive care options with the goal of meeting the needs of all their patients.

While there are many factors why patients with acute myeloid leukemia are ineligible for allogeneic stem cell transplant, such as age, financial hurdles, or other comorbidities, these factors are often compounded by social determinants of health, which can act as a significant barrier to consolidation therapy and long-term remission for these patients. In this episode, CANCER BUZZ speaks with Keri Maher, DO, Director of the Acute Leukemia Program, and assistant professor at Virginia Commonwealth University’s Massey Cancer Center about strategies to address these disparities and optimize care and treatment options for patients with acute myeloid leukemia who do not receive a transplant.

Learn how recent guideline and treatment options by the National Comprehensive Cancer Network (NCCN) can optimize care for patients with MPNs. 

Hear suggestions for how to reduce financial hurdles and increase access to cancer diagnostics.

As cancer programs seek new ways to improve coordination of molecular testing, hear how precision medicine stewards can streamline testing processes to improve efficiency and improve the patient experience. 

As myeloproliferative neoplasms (MPNs) carry a significant symptom burden and oftentimes can require lifelong care coordination and close monitoring, hear how a strong multidisciplinary approach can impact shared decision-making and patient engagement. 

CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, about when to begin therapeutic care for myeloproliferative neoplasms (MPNs) and the urgency of treatment.

Multidisciplinary care coordination is especially important with aggressive cases of SCLC, as there may be several unique challenges to be addressed. Watch now! 

Learn about a nurse’s role in care planning, and engaging patients in education, and shared decision making for treatment goals and planning.

Hear why community practices need to monitor symptoms carefully and about a new tool that can help assess symptoms more accurately and help care teams form treatment plans.

Learn how multidisciplinary care coordination and timely diagnosis are critical in the health outcomes of patients with SCLC.

Discover how Emily Smith, MD, addresses determinants of health in her practice and best practice recommendations for high quality care.

CANCER BUZZ spoke to David Waterhouse, MD, MPH, Medical Oncologist and Hematologist at the Dana-Farber Brigham Cancer Center, Milford Regional Medical Center in Milford, MA. Hear how to engage patients in clinical trials and address barriers.

Dr. Sanjay Juneja discusses how he uses social media as a way to share information broadly with patients, help keep people up to date on new advances, and address medical misinformation.

Learn how precision medicine stewards are helping to bridge the gaps and challenges associated with cancer diagnostics and biomarker testing.

In the second of a three-part series on “changing the culture of oncology,” Dr. Sanjay Juneja shares three technologies he’s excited about and why. 

Dr. Sanjay Juneja explores how—with many cancers now being treated like a chronic disease—it may be time to cancel the term “a cure for cancer.” 

Tune-in as our expert discusses how and when to screen patients, and then connect them to available resources to better support patients’ financial needs.

In this episode, our experts examine challenges with oral anti-cancer therapies and provide methods to better support patients. 

Hear how to educate patients and their caregivers about the risks and benefits to oral therapies for breast cancer. 

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans. 

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans. 

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans. 

With the  emergence of oral cancer therapies, it is a very exciting time in cancer care.  But these treatments can come with adverse events.

Allen Beck and Rivka Shakow Beck were newlyweds when Allen was diagnosed with myelodysplastic syndrome. Allen and Rivka were thrust into a stressful situation, but financial advocate, Angie Santiago, CRCS, was ready to help.

Hear from Wendi Waugh, Director of Cancer Services, Southern Ohio Medical Center, as she discusses the implementation of a process improvement plan with a focus on enhancing care for patients with advanced NSCLC. 

Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC. 

Caring for patients with acute myeloid leukemia (AML) depends on many factors and can vary as much as the patients themselves.

Genetic counselors—as members of the cancer care team—can help patients better understand their cancer diagnosis, make informed treatment decisions, and navigate the financial costs of testing.

In this episode, we talk with an oncology program manager and member of the Financial Advocacy Network Advisory Committee about the great need this robust resource fills in helping relieve financial toxicity, so patients can focus on their cancer care.

In this episode, we talk with an experienced cancer center information technology (IT) professional about how the role of the IT professional in quality, patient-centered cancer care delivery and what lies ahead.

Three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care.

We sat down with ACCC President Krista Nelson, on how her personal experiences during the pandemic—and those of her colleagues and patients—deeply impacted her and influenced the development of her 2021-2022 ACCC President’s Theme.